PELICAN

Daily Ideas

Find this valuable? Click here to subscribe and receive these ideas straight to your inbox daily.
Pelican Alpha – Daily Ideas | December 12, 2025
Pelican Logo

Pelican Alpha – Daily Ideas | December 12, 2025

📢 Top Press Release Signals

RIME (9/10) | $5.3M Mkt Cap | $1.82 | TechnologyContracts & Proven Resource Expansions

  • Filing Date: 2025-12-11 | Drift: -7.1%
  • Summary: Contract expansion worth $6M (68% of EV). Multi-year SaaS deal with major paint manufacturer.
  • Event: Algorhythm Holdings announced a $6 million contract expansion with one of India's largest paint manufacturers, marking the largest expansion in company history. The deal accelerates projected Annual Recurring Revenue (ARR) to over $13 million.
  • Source: [Press]

GREE (7/10) | $30.5M Mkt Cap | $1.84 | TechnologyCorporate Actions

  • Filing Date: 2025-12-11 | Drift: -4.8%
  • Summary: Asset sale for $18M (26% of EV). Spartanburg property divestiture with additional earnouts.
  • Event: Greenidge Generation sold its 152-acre Spartanburg property for $18 million in cash plus up to $18 million in earnout payments, resolving liquidity constraints.
  • Source: [Press]

MPTI (7/10) | $161.5M Mkt Cap | $52.88 | TechnologyContracts & Proven Resource Expansions

  • Filing Date: 2025-12-11 | Drift: -4.1%
  • Summary: Defense contract award worth $20M (14% of EV). Production support for major U.S. air defense program.
  • Event: M-Tron Industries secured a $20 million production contract from a top U.S. Department of Defense prime contractor for RF components in a critical air defense system.
  • Source: [Press]

CCC (7/10) | $4.6B Mkt Cap | $7.71 | TechnologySignificant Capital Allocation

  • Filing Date: 2025-12-12 | Drift: +0.3%
  • Summary: New $500M buyback authorization (8.9% of EV). Follows full utilization of prior $300M program.
  • Event: CCC Intelligent Solutions authorized a new $500 million share repurchase program, replacing a fully utilized $300 million buyback from December 2024.
  • Source: [Press]

📈 Top Price Target Signals

OPAD (8/10) | $71.5M Mkt Cap | $1.79 | Real EstateNew PT +81%

  • Publish Date: 2025-12-11 | Drift: -7.2%
  • Signal: Industrial Alliance Securities set PT to $3.50
  • Upside to PT: +81%
  • Consensus: N/A
  • Source: [Article]

BEAT (8/10) | $73.0M Mkt Cap | $2.24 | HealthcareNew PT +189% Consensus >100%

  • Publish Date: 2025-12-11 | Drift: +18.1%
  • Signal: H.C. Wainwright set PT to $5.50
  • Upside to PT: +189%
  • Consensus Target: $5.00 | Upside to Consensus: +162.4%
  • Source: [Article]

NUVB (8/10) | $2.8B Mkt Cap | $8.45 | HealthcareNew PT +128% Consensus >50%

  • Publish Date: 2025-12-11 | Drift: +7.4%
  • Signal: H.C. Wainwright set PT to $18.00
  • Upside to PT: +128%
  • Consensus Target: $13.00 | Upside to Consensus: +64.9%
  • Source: [Article]

GCTS (8/10) | $85.1M Mkt Cap | $1.43 | TechnologyNew PT +107%

  • Publish Date: 2025-12-11 | Drift: -1.5%
  • Signal: H.C. Wainwright set PT to $3.00
  • Upside to PT: +107%
  • Consensus: N/A
  • Source: [Article]

GRRR (8/10) | $294.9M Mkt Cap | $14.12 | TechnologyNew PT +118% Consensus >100%

  • Publish Date: 2025-12-11 | Drift: -0.8%
  • Signal: Cantor Fitzgerald set PT to $31.00
  • Upside to PT: +118%
  • Consensus Target: $34.50 | Upside to Consensus: +143.1%
  • Source: [Article]

PHAT (7/10) | $1.0B Mkt Cap | $14.86 | HealthcareNew PT +92% Consensus >50%

  • Publish Date: 2025-12-11 | Drift: +2.3%
  • Signal: Raymond James set PT to $28.00
  • Upside to PT: +92%
  • Consensus Target: $22.40 | Upside to Consensus: +53.8%
  • Source: [Article]

BNTX (7/10) | $23.1B Mkt Cap | $94.67 | HealthcareNew PT +62% Consensus >50%

  • Publish Date: 2025-12-11 | Drift: -0.9%
  • Multiple Actions:
    • Berenberg Bank: Target $155.00 | Upside to PT: +62% | [Article]
    • H.C. Wainwright: Target $140.00 | Upside to PT: +44% | [Article]
  • Consensus Target: $144.75 | Upside to Consensus: +51.3%

GPCR (7/10) | $4.1B Mkt Cap | $66.60 | HealthcareNew PT +80%

  • Publish Date: 2025-12-11 | Drift: -3.9%
  • Signal: Jefferies set PT to $125.00
  • Upside to PT: +80%
  • Consensus Target: $100.00 | Upside to Consensus: +43.6%
  • Source: [Article]

CGON (7/10) | $3.4B Mkt Cap | $41.17 | HealthcareNew PT +70% Consensus >50%

  • Publish Date: 2025-12-11 | Drift: -0.4%
  • Signal: Wedbush set PT to $70.00
  • Upside to PT: +70%
  • Consensus Target: $69.50 | Upside to Consensus: +68.3%
  • Source: [Article]

IKT (7/10) | $114.6M Mkt Cap | $1.51 | HealthcareNew PT +167%

  • Publish Date: 2025-12-11 | Drift: +1.0%
  • Signal: Cantor Fitzgerald set PT to $4.00
  • Upside to PT: +167%
  • Consensus: N/A
  • Source: [Article]

LBRX (7/10) | $511.8M Mkt Cap | $19.42 | HealthcareNew PT +64% Consensus >50%

  • Publish Date: 2025-12-11 | Drift: -9.5%
  • Signal: Stifel Nicolaus set PT to $35.00
  • Upside to PT: +64%
  • Consensus Target: $34.50 | Upside to Consensus: +61.5%
  • Source: [Article]

DYN (7/10) | $2.8B Mkt Cap | $19.44 | HealthcareNew PT +98% Consensus >50%

  • Publish Date: 2025-12-11 | Drift: -1.4%
  • Signal: Stifel Nicolaus set PT to $39.00
  • Upside to PT: +98%
  • Consensus Target: $38.11 | Upside to Consensus: +93.6%
  • Source: [Article]

PVLA (7/10) | $1.1B Mkt Cap | $97.39 | HealthcareNew PT +97%

  • Publish Date: 2025-12-11 | Drift: +0.5%
  • Signal: H.C. Wainwright set PT to $190.00
  • Upside to PT: +97%
  • Consensus Target: $141.67 | Upside to Consensus: +46.7%
  • Source: [Article]

MIRM (7/10) | $3.4B Mkt Cap | $64.53 | HealthcareNew PT +69% Consensus >50%

  • Publish Date: 2025-12-11 | Drift: -1.1%
  • Signal: Raymond James set PT to $110.00
  • Upside to PT: +69%
  • Consensus Target: $98.00 | Upside to Consensus: +50.5%
  • Source: [Article]

SLNH (7/10) | $144.4M Mkt Cap | $2.02 | TechnologyNew PT +156%

  • Publish Date: 2025-12-11 | Drift: +2.1%
  • Signal: H.C. Wainwright set PT to $5.00
  • Upside to PT: +156%
  • Consensus: N/A
  • Source: [Article]

RGTI (7/10) | $8.9B Mkt Cap | $25.91 | TechnologyNew PT +91%

  • Publish Date: 2025-12-11 | Drift: -1.7%
  • Signal: Mizuho Securities set PT to $50.00
  • Upside to PT: +91%
  • Consensus Target: $37.50 | Upside to Consensus: +43.5%
  • Source: [Article]

FULC (6/10) | $692.7M Mkt Cap | $12.90 | HealthcareConsensus >50%

  • Publish Date: 2025-12-11 | Drift: +1.9%
  • Signal: Truist Financial set PT to $18.00
  • Upside to PT: +42%
  • Consensus Target: $20.71 | Upside to Consensus: +63.8%
  • Source: [Article]

OLMA (6/10) | $2.2B Mkt Cap | $32.13 | HealthcareNew PT +52%

  • Publish Date: 2025-12-11 | Drift: +1.4%
  • Multiple Actions:
    • Oppenheimer: Target $48.00 | Upside to PT: +52% | [Article]
    • H.C. Wainwright: Target $45.00 | Upside to PT: +40% | [Article]
  • Consensus Target: $42.80 | Upside to Consensus: +35.2%

JEF (6/10) | $13.0B Mkt Cap | $61.73 | Financial ServicesNew PT +53%

  • Publish Date: 2025-12-11 | Drift: -2.5%
  • Signal: Oppenheimer set PT to $97.00
  • Upside to PT: +53%
  • Consensus Target: $76.00 | Upside to Consensus: +19.8%
  • Source: [Article]

WIX (6/10) | $5.7B Mkt Cap | $103.20 | TechnologyConsensus >50%

  • Publish Date: 2025-12-11 | Drift: -1.9%
  • Signal: Cantor Fitzgerald set PT to $140.00
  • Upside to PT: +33%
  • Consensus Target: $184.80 | Upside to Consensus: +75.9%
  • Source: [Article]

CHWY (6/10) | $14.2B Mkt Cap | $33.58 | Consumer Cyclical

  • Publish Date: 2025-12-11 | Drift: -5.1%
  • Multiple Actions:
    • Goldman Sachs: Target $52.00 | Upside to PT: +47% | [Article]
    • Barclays: Target $52.00 | Upside to PT: +47% | [Article]
  • Consensus Target: $47.71 | Upside to Consensus: +34.7%

PPC (6/10) | $9.4B Mkt Cap | $39.98 | Consumer Defensive

  • Publish Date: 2025-12-11 | Drift: +4.0%
  • Signal: Banco Santander set PT to $56.00
  • Upside to PT: +46%
  • Consensus Target: $50.50 | Upside to Consensus: +31.4%
  • Source: [Article]

QBTS (6/10) | $9.8B Mkt Cap | $26.25 | TechnologyNew PT +72%

  • Publish Date: 2025-12-11 | Drift: -2.8%
  • Signal: Mizuho Securities set PT to $46.00
  • Upside to PT: +72%
  • Consensus Target: $38.50 | Upside to Consensus: +43.7%
  • Source: [Article]

💼 Top Insider Buying Signals

MDRR (9/10) | $14.5M Mkt Cap | $13.00 | Real Estate>$1M Buy Cluster (2)

  • Filing Date: 2025-12-11
  • Multiple Transactions:
    • Kavanaugh Frank (Director, 10% Owner, Officer: Chairman, CEO & President) bought $1,030,000 @ $14.71 | Return: -11.7%
      • Position Change: +30.5% increase
      • Source: [Form 4]
    • Winn Charles Brent Jr. (Officer: CFO) bought $5,062 @ $12.66 | Return: +2.7%
      • Position Change: +0.7% increase
      • Source: [Form 4]

CE (7/10) | $4.7B Mkt Cap | $43.88 | Basic Materials>84% Own. Inc.

  • Filing Date: 2025-12-11 | Return: +7.1%
  • Signal: Kyrish Chuck (Officer: Svp & CFO) bought $205,150 @ $41.03
  • Position Change: +84.5% increase
  • Source: [Form 4]

WEST (7/10) | $405.7M Mkt Cap | $4.55 | Consumer Defensive

  • Filing Date: 2025-12-11 | Return: +10.1%
  • Signal: Ford Scott T (Director, 10% Owner, Officer: CEO) bought $414,000 @ $4.14
  • Position Change: +24.6% increase
  • Source: [Form 4]

NWPP (6/10) | $82.8M Mkt Cap | $3.51 | Financial Services

  • Filing Date: 2025-12-11 | Return: -3.8%
  • Signal: White Blaine Scott (Director, 10% Owner:) bought $370,475 @ $3.65
  • Position Change: +10.0% increase
  • Source: [Form 4]

DFDV (6/10) | $179.3M Mkt Cap | $5.72 | Technology

  • Filing Date: 2025-12-11 | Return: -1.0%
  • Signal: White Parker (10% Owner, Officer: COO, Chief Investment Officer) bought $102,298 @ $5.76
  • Position Change: +7.0% increase
  • Source: [Form 4]

Scoring Methodology

Press Release Signals

  • Scores reflect durable financial impact vs. market cap after adjustments.
  • Top signals: spin-offs/divestitures, multi-year gov/blue-chip contracts, buybacks/special dividends, activist campaigns, and balance-sheet de-risking.

Special Situation Signals

  • Focuses on structural market inefficiencies and event-driven opportunities.
  • Top Signals: Odd-lot tender offers (arb), massive buybacks (>15% of float), broken deals (forced selling), and hostile activism.

Price Target Signals

  • Points are awarded for the upside implied by a new target, the existing consensus upside, and the quality of the analyst's firm.
  • Top Signals: A new price target from an elite firm (e.g., Goldman Sachs, JP Morgan) that implies over 100% upside.

Insider Buying Signals

  • Scoring is based on the insider's role, the dollar value, and the percentage increase in holdings. Bonuses are awarded for clusters.
  • Top Signals: A C-Suite executive (CEO/CFO) making a >$1M purchase that significantly increases their personal stake (>50%).

Congressional Buying Signals

  • Scoring is based on the minimum dollar value of the disclosed purchase. Bonuses are awarded for clusters.
  • Top Signals: A large single purchase (min value >$100k) combined with a bipartisan cluster of three or more members.

Quantitative Screen Signals

  • A high score indicates a company excels across valuation, business quality, and financial health metrics.
  • Top Signals: Elite valuation (e.g., EV/FCF < 10), exceptional business quality (e.g., ROIC > 20%), and strong analyst consensus.

Important Disclosures and Disclaimer

Nature of Report:

This report is a proprietary research product of Pelican Alpha ("Pelican"). It is provided for informational and discussion purposes only and is based on Pelican's internal analysis and opinions as of the date stated.

Not Investment Advice:

This report is not and should not be construed as investment advice, a recommendation to buy or sell any security, or an offer to provide advisory services. The information contained herein does not consider the specific investment objectives, financial situation, or individual needs of any recipient. Recipients should consult with their own independent financial, tax, legal, and other advisors before making any investment decision.

No Fiduciary Relationship:

Pelican is not a registered investment advisor or broker-dealer. No fiduciary or advisory relationship is created by providing this report.

Accuracy and Completeness:

The information in this report is derived from sources believed to be reliable, but its accuracy, completeness, and timeliness are not guaranteed. Opinions, forecasts, and estimates are subject to change without notice and reflect Pelican's judgment at the time of preparation. Pelican is under no obligation to update this report.

Forward-Looking Statements:

This report may contain forward-looking statements that are inherently subject to risks and uncertainties. Actual results could differ materially from those anticipated. There is no assurance that any projected outcomes, catalysts, or expectations will be achieved.

Investment Risk:

Investing in securities involves the risk of loss. Past performance is not indicative of future results. The value of investments can fluctuate, and recipients may lose money. All risks discussed in this report (e.g., execution risk, market headwinds, competition) could negatively impact the investment.

Conflicts of Interest:

Pelican Alpha, its principals, analysts, employees, or affiliates may hold positions in the securities discussed in this report and may trade these positions at any time without notice.

No Liability:

Pelican Alpha assumes no liability for any direct, indirect, incidental, consequential, or other damages arising out of or in connection with the use of this report or the information contained herein.

Proprietary Material:

This report is confidential and proprietary to Pelican Alpha and may not be distributed or reproduced without prior written consent.

By reviewing this report, the recipient acknowledges and agrees to these terms. © 2025 Pelican Alpha. All rights reserved.